Aarthi Kannan

Ms. Aarthi Kannan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
BDBhaba Das
Bhaba Das
JGJyoti Gogoi
Jyoti Gogoi
AKAarthi Kannan
Aarthi Kannan
LGLing Gao
Ling Gao
WXWeirong Xing
Weirong Xing
HZHaibo Zhao
Haibo Zhao
Cytoskeleton organization and lysosome secretion play an essential role in osteoclastogenesis and bone resorption. The cytoplasmic dynein is a molecular motor complex that regulates microtubule dynamics and transportation of cargos/organelles, including lysosomes along the microtubules. LIS1, NDE1, and NDEL1 belong to an evolutionary conserved pathway that regulates dynein functions. Disruption of the cytoplasmic dynein complex and deletion of LIS1 in osteoclast precursors arrest osteoclastogenesis. Nonetheless, the role of NDE1 and NDEL1 in osteoclast biology remains elusive. In this study, we found that knocking-down Nde1 expression by lentiviral transduction of specific shRNAs markedly inhibited osteoclastogenesis in vitro by attenuating the proliferation, survival, and differentiation of osteoclast precursor cells via suppression of signaling pathways downstream of M-CSF and RANKL as well as osteoclast differentiation transcription factor NFATc1. To dissect how NDEL1 regulates osteoclasts and bone homeostasis, we generated Ndel1 conditional knockout mice in myeloid osteoclast precursors (Ndel1ΔlysM) by crossing Ndel1-floxed mice with LysM-Cre mice on C57BL/6J background. The Ndel1ΔlysM mice developed normally. The µCT analysis of distal femurs and in vitro osteoclast differentiation and functional assays in cultures unveiled the similar bone mass in both trabecular and cortical bone compartments as well as intact osteoclastogenesis, cytoskeleton organization, and bone resorption in Ndel1ΔlysM mice and cultures. Therefore, our results reveal a novel role of NDE1 in regulation of osteoclastogenesis and demonstrate that NDEL1 is dispensable for osteoclast differentiation and function.

30 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KKKrishnaswamy Kannan
Krishnaswamy Kannan
ASAlagarsamy Srinivasan
Alagarsamy Srinivasan
AKAarthi Kannan
Aarthi Kannan
Nawab AliNawab Ali
Nawab Ali
Breast cancer (BC) remains a leading cause of cancer related mortality among women worldwide. Despite significant advances in early detection and targeted therapies, treatment of resistant cancers continues to be a major hindrance in long term patient outcomes. Therefore, a comprehensive understanding of the underlying mechanisms and strategies to overcome resistance in BC is urgently needed. Resistance is likely driven by diverse processes such as drug efflux transporter upregulation; genetic mutations and signaling rewiring (e.g., ESR1, PIK3CA/PTEN, PI3K/Akt/mTOR); cancer stem cells and exosome RNA transfer; modulation of tumor microenvironment; epigenetic and metabolic reprogramming; and immune evasion—all of which compromise treatment efficacy. As tumors evolve, monotherapies rapidly lose effectiveness, and metastatic progression further worsens outcomes. In this review, we systematically examine the key metabolic, genetic, epigenetic, immunological, and microenvironmental drivers of BC resistance and emerging strategies to treatments. Further, we also explore the role that artificial intelligence (AI) can play in enhancing early detection, clinical-decision making, developing targeted therapies, and designing vaccines, which can aid in overcoming resistance. By integrating mechanistic insights with cutting-edge technologies, our review highlights the potential of next-generation interventions to overcome resistance and improve patient prognosis and outcome.

9 January 2025 in Biology
Verified
Journal Article
Open access
PDF file
LWLei Wang
Lei Wang
TMTarun Minocha
Tarun Minocha
BDBhaba Das
Bhaba Das
MKMikaela Dea Kunika
Mikaela Dea Kunika
AKAarthi Kannan
Aarthi Kannan
HZHaibo Zhao
Haibo Zhao
There are three FAM98 family proteins (FAM98A/B/C) in humans and mice. Their physiological functions remain largely unknown. We have previously reported that Fam98a interacts with Plekhm1 in murine osteoclasts and functions in lysosome trafficking/secretion and bone resorption in osteoclasts in vitro. In this study, we found that all three Fam98 genes were expressed in precursor and mature osteoclasts. While the knockdown of Fam98c by a specific short-hairpin RNA (shRNA) in osteoclast precursors attenuated osteoclastogenesis, depletion of Fam98b by an shRNA specifically disrupted osteoclast lysosome trafficking and bone resorption with phenotypes similar to Fam98a shRNA-knockdown in our previous study. Loss of Fam98a in myeloid osteoclast precursors was dispensable for trabecular and cortical bone mass in mice, as well as osteoclastogenesis/bone resorption in vitro, possibly due to compensation by increased Fam98b expression in Fam98a-null osteoclasts. These findings indicate that the three Fam98 proteins play distinct roles in osteoclastogenesis and osteoclast function and need further investigation in future studies.

1 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
LWLei Wang
Lei Wang
TMTarun Minocha
Tarun Minocha
BDBhaba Das
Bhaba Das
MKMikaela Dea Kunika
Mikaela Dea Kunika
AKAarthi Kannan
Aarthi Kannan
HZHaibo Zhao
Haibo Zhao
There are three FAM98 family proteins (FAM98A/B/C) in human and mice. Their physiological functions remain largely unknown. We have previously reported that Fam98a interacts with Plekhm1 in murine osteoclasts and functions in lysosome trafficking/secretion and bone resorption in osteoclasts in vitro. In this study, we found that all three Fam98 genes were expressed in precursor and mature osteoclasts. While knockdown of Fam98c by a specific short-hairpin RNA (shRNA) in osteoclast precursors attenuated osteoclastogenesis, depletion of Fam98b by a shRNA specifically disrupted osteoclast lysosome trafficking and bone resorption with phenotypes similar to Fam98a shRNA-knockdown in our previous study. Loss of Fam98a in myeloid osteoclast precursors was dispensable for trabecular and cortical bone mass in mice as well as osteoclastogenesis/bone resorption in vitro, possibly due to compensation by increased Fam98b expression in Fam98a-null osteoclasts. These findings indicate that the three Fam98 proteins play distinct roles in osteoclastogenesis and osteoclast function, respectively, that need further investigation in future studies.